PEN
Penumbra Inc
NYSE: PEN · HEALTHCARE · MEDICAL DEVICES
$326.48
+0.51% today
Updated 2026-04-30
Market cap
$12.79B
P/E ratio
71.96
P/S ratio
9.11x
EPS (TTM)
$4.53
Dividend yield
—
52W range
$221 – $362
Volume
0.6M
Penumbra Inc (PEN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $71.15M | $121.38M | $263.85M | $308.25M | $476.67M | $515.01M | $665.90M | $822.98M | $1.24B | $1.37B | $1.56B | $1.53B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | — | $62.24M | $115.30M | $244.36M | $263.83M | $382.23M | $410.73M | $463.13M | $617.70M | $681.47M | $755.70M | $915.40M | $951.13M |
| Total liabilities | — | $79.21M | $133.75M | $31.33M | $41.71M | $76.26M | $92.59M | $180.29M | $185.19M | $290.32M | $372.03M | $377.36M | $382.25M |
| Current liabilities | — | $15.84M | $20.82M | $28.15M | $35.80M | $51.58M | $66.06M | $91.05M | $105.93M | $123.20M | $144.93M | $151.14M | $158.34M |
| Long-term debt | — | $6.00M | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | — | $-14.99M | $-19.84M | $-17.48M | $-2.66M | $2.00M | $9.06M | $57.52M | $40.62M | $45.91M | $43.90M | $134.86M | $60.00M |
| Accounts receivable | — | $13.15M | $20.57M | $29.44M | $43.34M | $58.01M | $81.90M | $105.90M | $114.61M | $133.94M | $203.38M | $201.77M | $167.67M |
| Inventory | — | $27.07M | $33.45M | $56.76M | $73.01M | $94.90M | $115.74M | $152.99M | $219.53M | $263.50M | $334.01M | $388.02M | $406.74M |
| Goodwill | — | — | — | $0.00 | $0.00 | $8.18M | $7.81M | $7.66M | $8.37M | $166.39M | $166.05M | $166.27M | $165.83M |